D-0650-2024 Class II Ongoing
FDA drug recall D-0650-2024 was initiated by ProRx LLC on Aug 22, 2024 and is designated Class II. Reason for recall: Lack of Assurance of Sterility The recall status is ongoing. Affected quantity: 2,490 vials.
Recall details
- Product Type
- Drugs
- Report Date
- Sep 11, 2024
- Initiation Date
- Aug 22, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 2,490 vials
Product description
Semaglutide, 2 mL (2.5mg/mL), Compounded RX Product, Multidose SC inj, glass vial, ProRx, 267-565-7008, NDC 84139-225-01
Reason for recall
Lack of Assurance of Sterility
Distribution pattern
Nationwide in the USA
Code information
Lot #: ProRx031924, BUD 09/18/2024 ProRx032624, BUD 09/25/2024 ProRx041324, BUD 10/12/2024
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0650-2024
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026